Market Report of China’s Biopharmaceuticals Industry in 2009SunFAITH China Ltd.September 27, 2010 12 Pages - SKU: CJFQ2825164 |
| Countries covered: China Despite the impact of global financial downturn, the emerging pharmaceutical markets have made good showings. Likewise, Chinese biopharmaceuticals industry also presented growth tendency. Up till November 2009, the cumulative industrial sales value of China’s biological and biopharmaceutical product manufacturing industries rose 27.34% to RMB 78.703 billion compared to the same period of the year before with a growth rate dropping 3.95 percentage points. By analyzing China’s biopharmaceuticals industry in terms of the production, trade, market and financial information of prime products, this report makes prediction as reference about the future developing path of the national biopharmaceuticals industry. |
More China Biopharmaceuticals Reports
Research Report on Chinese Bio-pharmaceutical Industry, 2012 by
China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). ...
Biosimilars: China Update by
Datamonitor
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key ...
Biosimilars: China Update by
Datamonitor
Currently, there is no definition, guidance or pathway for biosimilars in China, with domestically manufactured versions of biologics, known as biogenerics. Due to limited R&D ...
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (4th edition) by
Access China Management Consulting Ltd.
The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and ...
Research Report on China's Biopharmaceutical Industry, 2010-2012 by
China Research and Intelligence Co., Ltd.
In China, biological products for human use include bacterial vaccines (including toxoid), viral vaccines, antitoxin and immune serum, blood products, cytokines, in vivo and in ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Biopharmaceuticals Reports
- Research Report on Chinese Bio-pharmaceutical Industry, 2012
- Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
- Biologics Market in Brazil
- Global Biosimilars Market Forecast to 2015
- Biosimilars: Current Situation & Future Prospects, Worldwide
